Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Melatonin Dosage for Effective Sedation, Hemodynamic Stability and Pain Control in Functional Endoscopic Sinus Surgery (FESS)

NCT07550751 is registered in ClinicalTrials.gov with Aswan University Hospital as lead sponsor.

NCT NCT07550751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07550751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Melatonin Dosage for Effective Sedation, Hemodynamic Stability and Pain Control in Functional Endoscopic Sinus Surgery (FESS)
Lead sponsor
Aswan University Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2024
Completion date
October 1, 2025
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical trial